您要查找的是不是：
- HBV DNA recombinant vaccine 重组（酵母）乙肝疫苗
- To construct a therapeutic HBV DNA vaccine and investigate its expression in mammalian cells. 摘要目的构建一种治疗性的乙肝DNA疫苗并测定它的表达。
- The present researches have pointed out that HBV DNA Vaccine will become a new vaccine to prevent and treat Hepatitis B in the future. 目前研究认为，乙型肝炎DNA疫苗很可能成为预防和治疗乙型肝炎的全新一代疫苗。
- This includes HBV antigen positive dendritic cells or we just call it HBV DNA vaccine or we call it the cytokine-induced killer cells, CIK cells. 包括：HBV 抗原性阳性的树突状细胞，或我们称为“HBV DNA疫苗”，以及我们称为“细胞因子诱导的杀伤细胞（CIK细胞）”。
- They were divided by HBsAg and HBV DNA into 4 groups. 按血清HBsAg及乙肝病毒脱氧核糖核酸(HBV DNA)检测结果分组。
- Objective:To study the relationship between HBV M and HBV DNA. 目的:研究乙肝病毒血清学标志物(HBV M)与乙肝病毒脱氧核糖核酸(HBV DNA)之间的关系。
- A COMPARATAREL STUDY OF PCR FOR HBV DNA AND ELISA FOR HBV MARKERS. PCR法检测食品从业人员血清中的HBV-DNA与ELISA法检测结果比较
- Prevent and Therapeutic Antitumor Response to Cervical Cancer in Mice Immunized with U14 Cell Vaccines Transfected with Costimulatory B7 Gene and HPV16E6/B7 DNA Recombinant Vaccines B7修饰的U14细胞疫苗和HPV16E6/B7重组基因疫苗预防及治疗宫颈癌实验研究
- HBV DNA was observed both in the cytoplasm and nuclei of hepatocytes. HBVDNA可见于受染肝细胞的胞核或胞浆内，而HDVRNA绝大部分见于肝细胞胞核。
- Relationship of HBV DNA and serum HBV marks in patients with hepatitis B. 水平与血清标志物的关系。
- The relationship between the amount of HBV DNA in serum and HBV markers. 乙型肝炎病毒DNA含量与血清标志物的关系。
- Analysis of correlation among HBV DNA, HBV preS1 antigen and HBV markers. 乙肝病毒DNA和前S1抗原及其标记物三者相关性分析
- LHBs of 171 CHB patients were not statistically different from HBV DNA(P>0.05). 171份乙肝患者HBV DNA、LHBs的检测结果显示:LHBs的检测结果与HBV DNA的检出结果差异无统计学意义(P>0.;05)。
- DNA recombinant technology have brought innovation to the biolog y technology, it can supply the strains with strong selectivity and ability of accumulating target metabolites. 重组DNA技术使生物技术取得了彻底性的变革，它可以提供具有极强选择性和累积目的代谢物能力的菌株。
- Hepatitis B vaccines progressed from blood vaccines to recombinant vaccines,then to peptide vaccines and DNA vaccines,to their functions extended from prophylactic to therapeutic. 从第一代血源性疫苗到重组乙肝疫苗,再到合成肽疫苗和DNA疫苗,乙肝疫苗的研制技术不断进步,其应用范围也已从预防扩展到治疗。
- Results The positive rate of HBVDNA was 56.7%,and the level of HBV DNA was 4.16+0.57(LogE,copies/ml)in saliva. 结果60例慢性HBV 感染者中唾液HBV DNA 阳性34例;平均HBV DNA 含量为4.;16±0
- Quantitative detection of serum HBV DNA is useful in assessment of liver damage and guidance in antivirus therapy. 定量检测HBVDNA对判断肝损害程度、指导抗病毒治疗有重要意义
- Hepatitis B vaccines progressed from blood vaccines to recombinant vaccines, then to peptide vaccines and DNA vaccines, to their functions extended from prophylactic to therapeutic. 从第一代血源性疫苗到重组乙肝疫苗，再到合成肽疫苗和DNA疫苗，乙肝疫苗的研制技术不断进步，其应用范围也已从预防扩展到治疗。
- Methods The pCI neo KH ORF expression vector was constructed by DNA recombinant technique and was introduced into COS 7 cells and K562 cells by lipofectactin mediated DNA transfection. Expression of KH ORF mRNA was detected by RT PCR. 方法 采用DNA重组技术构建KH ORF的表达载体pCI neo KH ORF ,通过脂质体法转染COS 7细胞和K5 6 2细胞 ,RT PCR检测目的基因的表达。
- The percent age of HBV DNA(+)in patients with both eAg (-) and eAb(+) was 26.13%. eAg(-)同时eAb(+)者中HBVDNA(+)占26.;13%25。
